Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals

Dana E. Layo-Carris,Emily E. Lubin,Annabel K. Sangree,Kelly J. Clark,Emily L. Durham,Elizabeth M. Gonzalez,Sarina Smith,Rajesh Angireddy,Xiao Min Wang,Erin Weiss,Roberto Mendoza-Londono,Lucie Dupuis,Nadirah Damseh,Danita Velasco,Irene Valenzuela,Marta Codina-Solà,Catherine Ziats,Jaclyn Have,Katie Clarkson,Dora Steel,Manju Kurian,Katy Barwick,Diana Carrasco,Aditi I. Dagli,M. J. M. Nowaczyk,Miroslava Hančárová,Šárka Bendová,Darina Prchalova,Zdeněk Sedláček,Alica Baxová,Catherine Bearce Nowak,Jessica Douglas,Wendy K. Chung,Nicola Longo,Konrad Platzer,Chiara Klöckner,Luisa Averdunk,Dagmar Wieczorek,Ilona Krey,Christiane Zweier,Andre Reis,Tugce Balci,Marleen Simon,Hester Y. Kroes,Antje Wiesener,Georgia Vasileiou,Nikolaos M. Marinakis,Danai Veltra,Christalena Sofocleous,Konstantina Kosma,Joanne Traeger Synodinos,Konstantinos A. Voudris,Marie-Laure Vuillaume,Paul Gueguen,Nicolas Derive,Estelle Colin,Clarisse Battault,Billie Au,Martin Delatycki,Mathew Wallis,Lyndon Gallacher,Fatma Majdoub,Noor Smal,Sarah Weckhuysen,An-Sofie Schoonjans,R. Frank Kooy,Marije Meuwissen,Benjamin T. Cocanougher,Kathryn Taylor,Carolyn E. Pizoli,Marie T. McDonald,Philip James,Elizabeth R. Roeder,Rebecca Littlejohn,Nicholas A. Borja,Willa Thorson,Kristine King,Radka Stoeva,Manon Suerink,Esther Nibbeling,Stephanie Baskin,Gwenaël L. E. Guyader,Julie Kaplan,Candace Muss,Deanna Alexis Carere,Elizabeth J. K. Bhoj,Laura M. Bryant
DOI: https://doi.org/10.1038/s41431-024-01610-1
2024-04-28
European Journal of Human Genetics
Abstract:Bryant-Li-Bhoj syndrome (BLBS), which became OMIM-classified in 2022 (OMIM: 619720, 619721), is caused by germline variants in the two genes that encode histone H3.3 ( H3-3A / H3F3A and H3-3B / H3F3B ) [1–4]. This syndrome is characterized by developmental delay/intellectual disability, craniofacial anomalies, hyper/hypotonia, and abnormal neuroimaging [1, 5]. BLBS was initially categorized as a progressive neurodegenerative syndrome caused by de novo heterozygous variants in either H3-3A or H3-3B [1–4]. Here, we analyze the data of the 58 previously published individuals along 38 unpublished, unrelated individuals. In this larger cohort of 96 people, we identify causative missense, synonymous, and stop-loss variants. We also expand upon the phenotypic characterization by elaborating on the neurodevelopmental component of BLBS. Notably, phenotypic heterogeneity was present even amongst individuals harboring the same variant. To explore the complex phenotypic variation in this expanded cohort, the relationships between syndromic phenotypes with three variables of interest were interrogated: sex, gene containing the causative variant, and variant location in the H3.3 protein. While specific genotype-phenotype correlations have not been conclusively delineated, the results presented here suggest that the location of the variants within the H3.3 protein and the affected gene ( H3-3A or H3-3B) contribute more to the severity of distinct phenotypes than sex. Since these variables do not account for all BLBS phenotypic variability, these findings suggest that additional factors may play a role in modifying the phenotypes of affected individuals. Histones are poised at the interface of genetics and epigenetics, highlighting the potential role for gene-environment interactions and the importance of future research.
genetics & heredity,biochemistry & molecular biology
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper attempts to expand the understanding of the phenotypic spectrum of Bryant - Li - Bhoj syndrome (BLBS) and explore its genotype - phenotype relationship. Specifically, the paper analyzed the data of 58 published individuals and 38 unpublished individuals, a total of 96 individuals, to identify missense mutations, synonymous mutations, and stop - codon - loss mutations that lead to BLBS. In addition, the paper also described in detail the neurodevelopmental characteristics of BLBS and explored the reasons for phenotypic heterogeneity. ### Main research contents 1. **Expanding the phenotypic spectrum**: - By analyzing the data of 96 individuals, the paper described in detail the multiple phenotypic characteristics of BLBS, including developmental delay/intellectual disability, craniofacial abnormalities, abnormal muscle tone, and abnormal neuroimaging findings. 2. **Genotype - phenotype relationship**: - The effects of gender, the affected genes (H3 - 3A or H3 - 3B), and the position of the mutation in the H3.3 protein on the phenotype were explored. - It was found that the mutation position and the affected gene have a greater impact on the severity of different phenotypes, while gender contributes less to phenotypic variation. 3. **Phenotypic heterogeneity**: - Phenotypic heterogeneity exists even among individuals with the same mutation, indicating that other factors (such as gene - environment interactions) may play a role in regulating the phenotype. 4. **Analysis of specific mutations**: - Individuals carrying the same missense mutation but located in different genes, as well as individuals carrying different mutations but affecting the same amino acid residue, were analyzed to explore the specific effects of these mutations on the phenotype. ### Main findings - **Growth abnormalities**: - More than half of the BLBS individuals showed typical age - and gender - related growth, but 41% of the individuals had a height trajectory outside the normal range, and most of them showed growth deficiency. - Individuals with mutations located in the H3.3 tail more often showed growth deficiency, while individuals with mutations located in the core region more often showed average height. - **Craniofacial abnormalities**: - 92% of BLBS individuals showed craniofacial abnormalities. Common features included a wide/prominent forehead, a wide nasal bridge, a thin upper lip, hypertelorism, epicanthal folds, and ear and tooth abnormalities. - Approximately 46% of individuals with craniofacial abnormalities also had microcephaly or macrocephaly, with microcephaly being more common. - **Neuroimaging abnormalities**: - 79% of BLBS individuals underwent diagnostic magnetic resonance imaging (MRI), and 58% of the individuals were diagnosed with at least one abnormal finding. Common abnormalities included delayed or hypomyelination, agenesis of the corpus callosum, ventricular dilatation, and multi - structural hemispheric asymmetry. - Individuals with mutations located in the tail more often reported abnormal findings, and men more often reported abnormal findings than women. - **Developmental milestones**: - 99% of BLBS individuals had developmental delay/intellectual disability, and many individuals also had comorbidities such as autism spectrum disorder, attention - deficit disorder, and anxiety disorder. - Individuals with tail mutations more often had delays in sitting and walking independently. - **Abnormal muscle tone**: - 84% of the individuals showed hypotonia, hypertonia, or axial hypotonia with peripheral hypertonia. - Hypotonia was more common in individuals with tail mutations, while axial hypotonia with peripheral hypertonia was only seen in individuals with core - region mutations. - **Other system abnormalities**: - Individuals also showed abnormalities in the musculoskeletal, skin, heart, and reproductive systems, with musculoskeletal abnormalities being the most common, followed by skin and heart abnormalities. ### Conclusions By expanding the research on BLBS individuals, the paper further clarifies the phenotypic spectrum and genotype - phenotype relationship of this syndrome. Although gender contributes less to phenotypic variation, the mutation position and the affected gene have a more significant impact on the phenotype. Future research needs to further explore the role of gene - environment interactions and other potential factors in regulating the BLBS phenotype.